Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus

Abstract

Objective

Prolactin (PRL) is known to aid effector B cells and augment autoimmunity, but the role of PRL in systemic lupus erythematosus (SLE) is not fully elucidated. The aim of this study was to determine the correlation between the serum levels of PRL and autoantibody production in SLE.

Methods

Blood levels of PRL, anti-double-stranded DNA (ds-DNA) antibody, immunoglobulin M (IgM) and immunoglobulin G (IgG) were determined in samples from 30 adult patients with SLE and 25 healthy controls. The relationships between the serum level of PRL and SLE disease activity, as well as the titres of the ds-DNA antibody, IgM and IgG were determined.

Results

The serum level of PRL was higher in the SLE patients than in the healthy controls. PRL concentration increased during SLE flares-ups and decreased following disease remission. There was a positive correlation between the PRL concentration and serum levels of IgM, IgG and ds-DNA antibody titre.

Conclusion

These data suggest that the serum level of PRL was closely related to the antibody production and disease activity of SLE patients. PRL concentration was dramatically reduced upon the remission of disease activity, indicating that PRL levels might be a promising predictor of SLE disease severity.

Keywords

Systemic lupus erythematosus prolactin antibody

Get full access to this article

View all access options for this article.

References

Arbuckle

McClain

Rubertone

. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533.

Yang

Chu

Yang

. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 1472–1483.

Shelly

Boaz

Orbach

. Prolactin and autoimmunity. Autoimmun Rev 2012; 11: A465–470.

Petri

. Sex hormones and systemic lupus erythematosus. Lupus 2008; 17: 412–415.

Costanza

Binart

Steinman

. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev 2015; 14: 223–230.

Matera

Mori

Galetto

. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 2001; 10: 728–734.

Jara

Benitez

Medina

. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008; 7: 251–255.

Moshirzadeh

Ghareghozli

Harandi

. Serum prolactin level in patients with relapsing–remitting multiple sclerosis during relapse. J Clin Neurosci 2012; 19: 622–623.

Ugarte-Gil

Gamboa-Cardenas

Zevallos

. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus 2014; 23: 969–974.

10.

Orbach

Shoenfeld

. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007; 6: 537–542.

11.

Ledesma-Soto

Blanco-Favela

Fuentes-Panana

. Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment. BMC Immunol 2012; 13: 11–11.

12.

Mendez

Alcocer-Varela

Parra

. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus 2004; 13: 45–53.

13.

Miranda

Prieto

Paniagua

. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 1998; 7: 387–391.

14.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

15.

Legorreta-Haquet

Flores-Fernandez

Blanco-Favela

. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease. Clin Dev Immunol 2013; 2013: 287469–287469.

16.

Correale

Farez

Ysrraelit

. Role of prolactin in B cell regulation in multiple sclerosis. J Neuroimmunol 2014; 269: 76–86.

17.

Sayki Arslan

Sahin

Topaloglu

. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol (Oxford) 2013; 79: 882–886.

18.

Yang

Huang

Liu

. Prolactin may be a promising therapeutic target for myasthenia gravis: hypothesis and importance. Med Hypotheses 2008; 70: 1017–1020.

19.

McMurray

Keisler

Izui

. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994; 71: 338–343.

20.

Saha

Tieng

Pepeljugoski

. Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models. Clin Rev Allergy Immunol 2011; 40: 8–15.

21.

Gubbay

Critchley

Bowen

. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab 2002; 87: 2329–2335.

22.

Vera-Lastra

Mendez

Jara

. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol 2003; 30: 2140–2146.

23.

Gutierrez

Molina

Jara

. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Imm 1996; 109: 229–235.

24.

Jacobi

Rohde

Ventz

. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001; 10: 554–561.

25.

Huang

Guo

Bao

. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PloS one 2011; 6: e21671–e21671.

26.

Jara

Vera-Lastra

Miranda

. Prolactin in human systemic lupus erythematosus. Lupus 2001; 10: 748–756.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB